Gerresheimer (GRRMF) Stock Price, News & Analysis

Company Overview

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Key Stats

• Today's Range: $73.80 to $73.80
• 50-Day Range: $64.07 to $83.00
• 52-Week Range: $64.07 to $114.50
• Volume: 350 shs
• Average Volume: 818 shs
• Market Capitalization: N/A
• P/E Ratio: 32.51
• Dividend Yield: 0.70%
• Price Target: N/A
• Consensus Rating: N/A

Gerresheimer Stock Analysis - MarketRank™

Gerresheimer scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Gerresheimer.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Gerresheimer is 32.51, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.18.

Price to Earnings Ratio vs. Sector

The P/E ratio of Gerresheimer is 32.51, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.01.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Gerresheimer has a short interest ratio ("days to cover") of 1915, which indicates bearish sentiment.

Change versus previous month

Short interest in Gerresheimer has recently increased by 47.53%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Gerresheimer pays a meaningful dividend of 1.30%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Gerresheimer does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Gerresheimer is 22.82%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Gerresheimer has a short interest ratio ("days to cover") of 1915, which indicates bearish sentiment.

Change versus previous month

Short interest in Gerresheimer has recently increased by 47.53%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Sentiment

Gerresheimer has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Gerresheimer this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Gerresheimer insiders have not sold or bought any company stock.

Percentage Held by Institutions

53.23% of the stock of Gerresheimer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

GRRMF Stock Analysis - Frequently Asked Questions

How have GRRMF shares performed this year?

Gerresheimer's stock was trading at $69.75 on January 1st, 2025. Since then, GRRMF shares have increased by 5.8% and is now trading at $73.80.
View the best growth stocks for 2025 here.

How do I buy shares of Gerresheimer?

Shares of GRRMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 5/30/2025
• Next Earnings (Estimated): 7/09/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:GRRMF
• CIK: N/A
• Web: www.gerresheimer.com
• Phone: 49 211 6181 00
• Fax: N/A
• Employees: 11,947
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 32.51
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A